A user researching myostatin inhibitors noted that while there are frequently expressed concerns regarding heart and organ hypertrophy associated with Follistatin 344, their personal investigation led them to believe these risks might be overstated. They suggested that the peptide may not be as dangerous as commonly claimed in fitness circles.